• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Estradiol Levels Predict Fracture Risk During the Menopausal Transition

Slideshow

Authors of a new study found that estradiol levels can be used to predict fracture risk among women during the menopausal transition. 

Related Content
Menopause Survey Finds Sleep, Mood, and Seasonal Symptoms Most Disruptive / image credit ©Monkey Business/stock.adobe.com

New Menopause Survey Finds Energy Loss, Poor Sleep, and Seasonal Symptoms Most Disruptive

Grace Halsey
October 17th 2025
Article

The survey of more than 19,000 American women found low energy and sleep problems more disruptive than VMS and that Autumn is the most symptomatic season.

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Sydney Jennings
September 24th 2025
Podcast

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose / Image credit: ©New Africa/AdobeStock

Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose

Sydney Jennings
October 16th 2025
Article

Your daily dose of the clinical news you may have missed.

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
August 28th 2025
Podcast

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

FDA Quietly Approves Another Generic Formulation of Abortion Drug Mifepristone image credit ©Casimiro/stock.adobe.com

FDA Quietly Approves Another Generic Formulation of Abortion Drug Mifepristone

Grace Halsey
October 3rd 2025
Article

FDA did not announce the September 30 approval, which took place despite strong partisan opposition and during an uncompleted review of the drug's safety.

Lipocene Updates Progress on Phase 3 Clinical Trial in Postpartum Depression with LPCN 1154 / image courtesy of Lipocene

Lipocine Updates Progress on Phase 3 Clinical Trial in Postpartum Depression with LPCN 1154

Grace Halsey
October 1st 2025
Article

Lipocene expects to announce interim safety data from the study this quarter and said the phase 3 program results will support the company's NDA in 2026.

© 2025 MJH Life Sciences

All rights reserved.